PATENT CLAIM ANALYSIS

Application Number: 15752290
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "256000"]

Abstract:
Disclosed are a preparation method of an orexin receptor antagonist compound 5-3, Crystalline forms I-IV of an orexin receptor antagonist compound 5-3 are provided. Also provided are processes of the preparing the orexin receptor antagonist compound 5-3 and its crystalline forms, as well as methods of using the crystalline forms I-IV for treating an orexin-related disease.

Claim (Index 17):
The process of  claim 16 , wherein,\n the organic solvent is selected from C 1-6  alkyl alcohol, C 5-10  alkane or cycloalkane, C 4-10  ether or cyclic ether, C 3-7  ketone, C 2-6  ester, acetonitrile, or benzene optionally substituted by methyl, ethyl or halogen atoms, wherein the number of substituent is selected from 1, 2 or 3; the polar organic solvent is selected from C 1-6  alkyl alcohols, C 2-6  esters, acetonitrile or dichloromethane; and the weak polar or non-polar organic solvent is selected from C 5-10  alkane or cycloalkane, C 4-10  ether or cyclic ether, petroleum ether, or benzene optionally substituted by methyl or ethyl or halogen atoms, wherein the number of substituent is selected from 1, 2 or 3.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.81818
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10087112', '15580167', '15032552', '15115440', '15772942']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7533918914444938
- 35 USC 102 Novelty (BERT): 0.5070109675505122
- Combined Prediction Score: 0.7287537990550956
- Mean Citation Score: 251.051674
- Max Citation Score: 272.06235
- Similarity Product: 225.457049460268

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test